questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Fibrose
Fibrose : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fibrose : Questions médicales les plus fréquentes",
"headline": "Fibrose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fibrose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-06",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fibrose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Processus pathologiques",
"url": "https://questionsmedicales.fr/mesh/D010335",
"about": {
"@type": "MedicalCondition",
"name": "Processus pathologiques",
"code": {
"@type": "MedicalCode",
"code": "D010335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cicatrice hypertrophique",
"alternateName": "Cicatrix, Hypertrophic",
"url": "https://questionsmedicales.fr/mesh/D017439",
"about": {
"@type": "MedicalCondition",
"name": "Cicatrice hypertrophique",
"code": {
"@type": "MedicalCode",
"code": "D017439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.274.505"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chéloïde",
"alternateName": "Keloid",
"url": "https://questionsmedicales.fr/mesh/D007627",
"about": {
"@type": "MedicalCondition",
"name": "Chéloïde",
"code": {
"@type": "MedicalCode",
"code": "D007627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.274.510"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adhérences tissulaires",
"alternateName": "Tissue Adhesions",
"url": "https://questionsmedicales.fr/mesh/D000267",
"about": {
"@type": "MedicalCondition",
"name": "Adhérences tissulaires",
"code": {
"@type": "MedicalCode",
"code": "D000267",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.274.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cirrhose du foie",
"alternateName": "Liver Cirrhosis",
"url": "https://questionsmedicales.fr/mesh/D008103",
"about": {
"@type": "MedicalCondition",
"name": "Cirrhose du foie",
"code": {
"@type": "MedicalCode",
"code": "D008103",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.412"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cirrhose biliaire",
"alternateName": "Liver Cirrhosis, Biliary",
"url": "https://questionsmedicales.fr/mesh/D008105",
"about": {
"@type": "MedicalCondition",
"name": "Cirrhose biliaire",
"code": {
"@type": "MedicalCode",
"code": "D008105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.412.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Fibrose systémique néphrogénique",
"alternateName": "Nephrogenic Fibrosing Dermopathy",
"url": "https://questionsmedicales.fr/mesh/D054989",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose systémique néphrogénique",
"code": {
"@type": "MedicalCode",
"code": "D054989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibrose péritonéale",
"alternateName": "Peritoneal Fibrosis",
"url": "https://questionsmedicales.fr/mesh/D056627",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose péritonéale",
"code": {
"@type": "MedicalCode",
"code": "D056627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibrose pulmonaire",
"alternateName": "Pulmonary Fibrosis",
"url": "https://questionsmedicales.fr/mesh/D011658",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D011658",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.644"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibrose rétropéritonéale",
"alternateName": "Retroperitoneal Fibrosis",
"url": "https://questionsmedicales.fr/mesh/D012185",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose rétropéritonéale",
"code": {
"@type": "MedicalCode",
"code": "D012185",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Fibrose",
"alternateName": "Fibrosis",
"code": {
"@type": "MedicalCode",
"code": "D005355",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nikolaos G Frangogiannis",
"url": "https://questionsmedicales.fr/author/Nikolaos%20G%20Frangogiannis",
"affiliation": {
"@type": "Organization",
"name": "The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: nikolaos.frangogiannis@einsteinmed.org."
}
},
{
"@type": "Person",
"name": "Pierre-Régis Burgel",
"url": "https://questionsmedicales.fr/author/Pierre-R%C3%A9gis%20Burgel",
"affiliation": {
"@type": "Organization",
"name": "Université Paris Cité and Institut Cochin, Inserm U1016, Paris, France."
}
},
{
"@type": "Person",
"name": "Jane C Davies",
"url": "https://questionsmedicales.fr/author/Jane%20C%20Davies",
"affiliation": {
"@type": "Organization",
"name": "National Heart & Lung Institute, Imperial College London, London, UK."
}
},
{
"@type": "Person",
"name": "Na Liu",
"url": "https://questionsmedicales.fr/author/Na%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Nanjing, Jiangsu, China."
}
},
{
"@type": "Person",
"name": "Ruoshui Li",
"url": "https://questionsmedicales.fr/author/Ruoshui%20Li",
"affiliation": {
"@type": "Organization",
"name": "The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Resolution of Liver Function Tests After Laparoscopic Common Bile Duct Exploration Versus Endoscopic Retrograde Cholangiopancreatography.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36866709",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348231161688"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of liver function test- and inflammation-based prognostic scores for coronavirus disease 2019: a single center study.",
"datePublished": "2022-09-10",
"url": "https://questionsmedicales.fr/article/36170686",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MEG.0000000000002446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35918381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-17618-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge.",
"datePublished": "2022-10-26",
"url": "https://questionsmedicales.fr/article/36289394",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22741-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37623002",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/curroncol30080521"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Fibrose",
"item": "https://questionsmedicales.fr/mesh/D005355"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fibrose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fibrose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fibrose",
"description": "Comment diagnostique-t-on la fibrose pulmonaire ?\nQuels tests sanguins sont utiles pour la fibrose ?\nLa fibrose peut-elle être détectée par échographie ?\nQuels sont les signes radiologiques de la fibrose ?\nLa fibrose peut-elle être confondue avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fibrose",
"description": "Quels sont les symptômes de la fibrose pulmonaire ?\nLa fibrose hépatique provoque-t-elle des douleurs ?\nQuels signes indiquent une fibrose cardiaque ?\nLa fibrose peut-elle entraîner une perte de poids ?\nQuels symptômes sont associés à la fibrose systémique ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fibrose",
"description": "Comment prévenir la fibrose pulmonaire ?\nPeut-on prévenir la fibrose hépatique ?\nLes examens réguliers aident-ils à prévenir la fibrose ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe contrôle des maladies chroniques aide-t-il ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fibrose",
"description": "Quels traitements existent pour la fibrose pulmonaire ?\nLa chirurgie est-elle une option pour la fibrose ?\nQuels médicaments sont utilisés pour la fibrose hépatique ?\nLa physiothérapie aide-t-elle en cas de fibrose ?\nY a-t-il des traitements naturels pour la fibrose ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fibrose",
"description": "Quelles sont les complications de la fibrose pulmonaire ?\nLa fibrose hépatique peut-elle entraîner une cirrhose ?\nQuels risques sont associés à la fibrose cardiaque ?\nLa fibrose peut-elle affecter la qualité de vie ?\nY a-t-il des complications psychologiques liées à la fibrose ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fibrose",
"description": "Quels sont les facteurs de risque de la fibrose pulmonaire ?\nL'âge est-il un facteur de risque pour la fibrose ?\nLes maladies auto-immunes augmentent-elles le risque de fibrose ?\nLe diabète est-il un facteur de risque pour la fibrose hépatique ?\nL'exposition professionnelle influence-t-elle le risque de fibrose ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la fibrose pulmonaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens d'imagerie, des tests fonctionnels pulmonaires et parfois une biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles pour la fibrose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests pour évaluer les marqueurs inflammatoires et la fonction hépatique peuvent être effectués."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle être détectée par échographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie peut aider à visualiser la fibrose dans certains organes comme le foie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes radiologiques de la fibrose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des opacités, des réticulations et des anomalies de la structure tissulaire."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle être confondue avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec des maladies comme la pneumonie ou la cirrhose."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la fibrose pulmonaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une toux persistante, un essoufflement et une fatigue chronique."
}
},
{
"@type": "Question",
"name": "La fibrose hépatique provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des douleurs abdominales et une sensation de lourdeur dans l'abdomen."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une fibrose cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des palpitations, un essoufflement à l'effort et des œdèmes."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle entraîner une perte de poids ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fibrose peut causer une perte de poids due à une mauvaise absorption des nutriments."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la fibrose systémique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs articulaires, une raideur cutanée et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir la fibrose pulmonaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, réduire l'exposition à des polluants et traiter les infections respiratoires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la fibrose hépatique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en adoptant un mode de vie sain, en évitant l'alcool et en se vaccinant contre l'hépatite."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à prévenir la fibrose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent détecter précocement des maladies pouvant mener à la fibrose."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée riche en antioxydants peut aider à prévenir la fibrose."
}
},
{
"@type": "Question",
"name": "Le contrôle des maladies chroniques aide-t-il ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien gérer des maladies comme le diabète ou l'hypertension peut réduire le risque de fibrose."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la fibrose pulmonaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments antifibrotiques, la réhabilitation pulmonaire et l'oxygénothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour la fibrose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certains cas avancés, une transplantation d'organe peut être envisagée."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour la fibrose hépatique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments pour traiter la cause sous-jacente, comme les antiviraux pour l'hépatite, sont utilisés."
}
},
{
"@type": "Question",
"name": "La physiothérapie aide-t-elle en cas de fibrose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut améliorer la fonction pulmonaire et la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour la fibrose ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines approches comme les antioxydants peuvent aider, mais il faut consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la fibrose pulmonaire ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire, les infections pulmonaires et les embolies."
}
},
{
"@type": "Question",
"name": "La fibrose hépatique peut-elle entraîner une cirrhose ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fibrose hépatique peut évoluer vers une cirrhose, entraînant des complications graves."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à la fibrose cardiaque ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent l'insuffisance cardiaque, les arythmies et les accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut réduire la qualité de vie en limitant les activités quotidiennes et en causant de la douleur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications psychologiques liées à la fibrose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent éprouver de l'anxiété et de la dépression en raison de leur état de santé."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la fibrose pulmonaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des substances toxiques et des infections antérieures."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour la fibrose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de fibrose augmente avec l'âge, surtout après 50 ans."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque de fibrose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérodermie peuvent prédisposer à la fibrose dans divers organes."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour la fibrose hépatique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le risque de fibrose hépatique en raison de la stéatose."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle influence-t-elle le risque de fibrose ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des professions exposant à des poussières ou des produits chimiques peuvent augmenter le risque."
}
}
]
}
]
}
Laparoscopic cholecystectomy (LC) with laparoscopic common bile duct exploration (LCBDE) is gaining traction for the management of choledocholithiasis. Liver function tests (LFTs) are often used to de...
Although several liver- and inflammation-based scores to predict the clinical course of patients with coronavirus disease 2019 (COVID-19) have been evaluated, no direct comparison regarding their pred...
1038 patients (608 males, age 63.5 ± 17 years) hospitalized with documented COVID-19 infection to the non-ICU ward, were included retrospectively. Clinical and laboratory characteristics on admission ...
One hundred and twenty-four patients (11.9%) died during hospitalization after 8 (3-72) days. In multivariate analysis, FIB-4 (hazard ratio, 1.11; 95% confidence interval (CI), 1.034-1.19; P = 0.004),...
FIB-4 was an independent factor for mortality with better performance compared to other liver function test- and inflammation-based scores in patients with COVID-19, while CAR was the only score indep...
The effect of induction chemotherapy on liver function in patients with acute lymphoblastic leukemia is not well documented in Ethiopia. This study assessed hepatotoxicity in patients with acute lymph...
This study investigated whether acute liver injury (ALI) persisted and identified predictors of ALI recovery [as indicated by alanine aminotransferase (ALT) level] at hospital discharge and 2 months p...
The aim of this study was to investigate the prognostic significance of PD-1 inhibitor therapy in nasopharyngeal carcinoma (NPC) and to develop a nomogram to estimate individual risks....
We retrospectively analyzed 162 NPC patients who were administered the PD-1 inhibitor combined with radiotherapy and chemotherapy at the Sun Yat-Sen University Cancer Center. In total, 108 NPC patient...
Univariate and multivariate analyses indicated that the metastasis stage, the levels of ALT, the AST/ALT ratio, and the LDH were independent risk factors associated with the prognosis of PD-1 inhibito...
Predicting PFS in NPC patients based on liver function-related indicators before PD-1 treatment may help clinicians predict the efficacy of PD-1 treatment in these patients....
To assess the predictive value of intraoperative indocyanine green (ICG) test in patients undergoing staged hepatectomy....
We analyzed intraoperative ICG measurements of future liver remnant (FLR), preoperative ICG, volumetry, and hepatobiliary scintigraphy in 15 patients undergoing associated liver partition and portal v...
Median intraoperative R15 (ICG retention rate at 15 min) correlated significantly with CCI® at discharge (p = 0.05) and with CCI® at 90 days (p = 0.0036). Preoperative ICG, volumetry, and scintigraphy...
This pilot study suggests that intraoperative ICG clearance determines the functional capacity of the future liver remnant more accurately than preoperative tests. This may further reduce the number o...
Patients with liver disease can be stratified for risk of liver-related ill health by degree of hepatic fibrosis. The Enhanced liver fibrosis (ELF) test was developed to quantify hepatic fibrosis non-...
Searches of PubMed and EMBASE were conducted between October 2020 and November 2021 to identify studies reporting the diagnostic accuracy of the ELF test compared to histology in liver disease patient...
Meta-analysis revealed considerable variability in the ability of ELF to stage fibrosis across disease aetiologies. Research has mostly focused on viral hepatitis and NAFLD. There is currently a lack ...
Clinical laboratory examinations frequently include biochemical analysis of the liver. The presence of alanine aminotransferase (ALT) and aspartate transaminase (AST) in serum can be used to identify ...
Pre-eclampsia can be described as new-onset hypertension (blood pressure ≥140/90 mmHg) together with proteinuria (24-hr urinary protein ≥ 0.3 g) or any indication of end-organ damage after 20 weeks of...
An institutional-based comparative cross-sectional study design was conducted, and a total of 102 subjects (51 patients with preeclampsia and 51 normotensive pregnant women) were recruited. The parame...
There were statistically significant differences in the mean serum uric acid, ALT, and AST levels between preeclamptic pregnant women and normotensive pregnant women (p<0.05). There were no statistica...
Our study revealed that serum uric acid, ALT, and AST levels were higher in pre-eclamptic pregnant women compared to those of normotensive pregnant women, and the differences were statistically signif...
To assess the largely undetermined separate and joint effects of sleep and liver function biomarkers on liver cancer....
Data of 356,894 participants without cancer at baseline in the UK Biobank were analyzed. Sleep score was evaluated using five sleep traits (sleep duration, chronotype, insomnia, snoring, and excessive...
After a median follow-up time of 13.1 years, 394 cases of incident liver cancer were documented. The multivariable-adjusted hazard ratio (HR) for liver cancer was 1.46 (95% confidence interval: 1.15-1...
Unhealthy sleep was associated with an increased risk of liver cancer, especially in participants with lower ALB levels or higher levels of ALT, AST, TBIL, GGT, ALP, or particularly TP....